PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $141,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sageview Capital | 2,223,339 | $5,603,000 | 1.59% |
| Orbimed Advisors | 2,320,800 | $5,848,000 | 0.09% |
| F&C Asset Management plc | 1,854,808 | $4,665,000 | 0.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 56,500 | $142,000 | 0.04% |
| Yakira Capital Management, Inc. | 11,957 | $30,000 | 0.03% |
| Spectrum Management Group, LLC | 10,000 | $25,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 41,152 | $104,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 30,000 | $75,000 | 0.00% |
| PUTNAM INVESTMENTS LLC | 129,762 | $327,000 | 0.00% |
| Partnervest Advisory Services LLC | 220 | $1,000 | 0.00% |